Search

Drug Profiles Catalysts Company Profiles Impact Events Target
Indication Trials KOL Insight Special Reports All

Drug Impact Events

Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
1/30/15 BioMarin (BMRN) Drisapersen for Muscular Dystrophy Subscribers Only Subscribers Only Subscribers Only
1/30/15 Shire (SHPG) Vyvanse for Eating Disorders Subscribers Only Subscribers Only Subscribers Only
1/30/15 Sucampo (SCMP) Amitiza for Chronic Idiopathic Constipation Subscribers Only Subscribers Only Subscribers Only
1/30/15 Biotie (BTH1V:FH) Nepicastat for Drug Addiction Subscribers Only Subscribers Only Subscribers Only
1/29/15 Pharmacyclics (PCYC) Imbruvica for Waldenstrom Macroglobulinemia (WM) / Lymphoplasmacytic Lymphoma (LPL) - NHL Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

Expected
Date Range
Lead
Company
Drug Expected
Catalyst
01/30/15 Subscribers Only Subscribers Only Regulatory - PDUFA/Approval Decision (US)
01/31/15 Subscribers Only Subscribers Only Regulatory - PDUFA/Approval Decision (US)
Now - 02/02/15 Subscribers Only Subscribers Only Partnership - Option Exercise Decision
Now - 02/02/15 Subscribers Only Subscribers Only Company - Earnings Announcement
Now - 02/03/15 Subscribers Only Subscribers Only Company - Earnings Announcement